For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250502:nRSB1539Ha&default-theme=true
RNS Number : 1539H Coca-Cola Europacific Partners plc 02 May 2025
Coca-Cola Europacific Partners plc (the "Company")
Transactions in Own Shares and Programme Update
The Company confirms that on 01 May 2025 it purchased a total of: (i) 36,235
ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues(( 1
(#_ftn1) )) and (ii) 18,727 ordinary shares on the London Trading
Venues(( 2 )); in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs
International or one of their affiliates, as detailed below.
The repurchased ordinary shares will be cancelled.
The purchases form part of the Company's share buyback programme announced on
14 February 2025 (the "Programme"). In connection with the Programme, the
Company expects to repurchase up to EUR 1 billion of ordinary shares (in
aggregate). The Company announced on 28 March 2025 that the aggregate amount
for purchases in respect of the initial tranche of the Programme (expected to
be completed by 23 May 2025) was EUR 275,000,000, of which EUR 67,000,000
would be in respect of the London Trading Venues. The Company today announces
that whilst the aggregate amount in respect of the initial tranche remains the
same, the amount in respect of the London Trading Venues has been increased
from EUR 67,000,000 to EUR 76,000,000 (with purchases on the London Trading
Venues expected to be completed by 16 May 2025, as previously announced).
US Trading Venues London Stock Exchange CBOE Europe Limited CBOE Europe Limited Aquis
(CXE) (BXE)
Date of purchase 01 May 2025 01 May 01 May 2025 01 May 2025 01 May
2025 2025
Aggregate number of ordinary shares purchased 36,235 11,365 1,894 5,468 0
Highest price paid (per ordinary share) USD 90.0600 GBP 67.9000 GBP 67.9000 GBP 67.9000 GBP 0
Lowest price paid (per ordinary share) USD 89.3100 GBP 67.2000 GBP 67.2000 GBP 67.1000 GBP 0
Volume weighted average price paid (per ordinary share) USD 89.6804 GBP 67.6117 GBP 67.4955 GBP 67.4880 GBP 0
This announcement does not constitute, or form part of, an offer or
solicitation of an offer for securities in any jurisdiction.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), full details of the
transactions, are set out in the Schedule to this announcement available
through the link below:
http://www.rns-pdf.londonstockexchange.com/rns/1539H_1-2025-5-1.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1539H_1-2025-5-1.pdf)
CONTACTS
Company Secretariat Investor Relations Media Relations
Clare Wardle Sarah Willett Shanna Wendt
clare.wardle@ccep.com (mailto:clare.wardle@ccep.com) sarah.willett@ccep.com (mailto:sarah.willett@ccep.com) mediaenquiries@ccep.com (mailto:mediaenquiries@ccep.com)
ABOUT CCEP
Coca-Cola Europacific Partners is one of the world's leading consumer goods
companies. We make, move and sell some of the world's most loved brands -
serving nearly 600 million consumers and helping over 4 million customers
across 31 countries grow.
We combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.
The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock
Exchange and on the Spanish Stock Exchanges, and a constituent of both the
Nasdaq 100 and FTSE 100 indices, trading under the symbol CCEP.
For more information about CCEP, please visit www.cocacolaep.com and follow
CCEP on LinkedIn
1 The "US Trading Venues" comprise Nasdaq and other applicable US trading
venues.
2 The "London Trading Venues" comprise the London Stock Exchange, CBOE
Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs
acquired CREST Depositary Interests on the London Trading Venues, which will
be cancelled together with the underlying shares they represent.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSSSUEFFEISEEI